ACE2 and asthma: Sputum cell ACE2 mRNA expression was detectable in 22 of 36 subjects with COPD (61.1%), and consistent with prior observations in subjects with asthma,17 it was significantly reduced in ICS users compared with in nonusers (Fig 1, A).